Skip to content

Depression: all studies

Page 750 of 1,034: studies 7,491 to 7,500 of 10,336, newest first. Back to the depression overview

Research

Functional Connectivity of Prefrontal Cortex in Various Meditation Techniques – A Mini-Review

International Journal of Yoga September 1, 2022 Mrithunjay Rathore, Meghnath Verma, Mohit Nirwan et al. 28 citations

Meditation is a practice of concentration and relaxation. In philosophical terms, it is a process of gaining self-consciousness. Although there is diversity in meditation (Mindfulness, compassion, transcendental, and focused attention meditation), interventions show that meditation practices improve prefrontal cortex (PFC) functions like cognition, self-awareness, attention, and memory and...

Psychedelic-Assisted Therapies in Patients With Serious Illness: Opportunities and Challenges

Psychiatric Annals September 1, 2022 Michael Ljuslin, Kabir Nigam, Roxanne Sholevar et al. 4 citations

In addition to physical symptoms and treatment burden, people affected by serious illness experience psychological, social, and spiritual distress. Medical professionals who care for them, including psychiatrists and other mental health clinicians, attend to these multiple dimensions of suffering with the hope and promise of improving patients' quality of life. Yet anxiety, depression,...

DOI: 10.3928/00485713-20220810-06 (opens in new tab) Anxiety Mental illness Psychological intervention Distress +5

Psychedelics for Psychiatric Disorders: Promise, Not Panacea

Psychiatric Annals September 1, 2022 Mitch Earleywine, Zachary Herrmann 5 citations

Initial promise and dire need have inspired the multiple research programs of the second psychedelic renaissance. Serotonergic psychedelics (psilocybin, lysergic acid diethylamide, and ayahuasca) have decreased end-of-life anxiety in cancer patients, treatment-resistant depression, alcohol dependence, social anxiety in autistic adults, and nicotine dependence when applied with supportive...

The use of psychoactive substances in the treatment of mental disorders

Alcoholism and Drug Addiction August 31, 2022 Katarzyna Karaś, Katarzyna Groblińska, Krzysztof Szczygieł et al.

Research on the use of psychoactive substances in mental disorder treatment has become increasingly important over the last 50 years. Numerous publications suggest their effectiveness in the treatment of many diseases, including depression and anxiety disorders, PTSD, psychoactive substance dependence, ADHD and Tourette’s Syndrome. Particularly noteworthy is the use of psychedelics such as...

DOI: 10.5114/ain.2021.111791 (opens in new tab) Full text (opens in new tab) Mental disorders Treatment Psychoactive substances.

Targeting default mode network connectivity with mindfulness-based fMRI neurofeedback: A pilot study among adolescents with affective disorder history

bioRxiv (Cold Spring Harbor Laboratory) August 25, 2022 Jiahe Zhang, Jovicarole Raya, Francesca Morfini et al. 4 citations preprint

ABSTRACT Adolescents experience alarmingly high rates of major depressive disorder (MDD), however, gold-standard treatments are only effective for ~50% of youth. Accordingly, there is a critical need to develop novel interventions, particularly ones that target neural mechanisms believed to potentiate depressive symptoms. Directly addressing this gap, we developed a mindfulness-based fMRI...

Randomised clinical non-inferiority trial of breathing-based meditation and cognitive processing therapy for symptoms of post-traumatic stress disorder in military veterans.

BMJ Open August 25, 2022 Peter J Bayley, R Jay Schulz-Heik, Julia S Tang et al.

Test whether Sudarshan Kriya Yoga (SKY) was non-inferior to cognitive processing therapy (CPT) for treating symptoms of post-traumatic stress disorder (PTSD) among veterans via a parallel randomised controlled non-inferiority trial. Outpatient Veterans Affairs healthcare centre. 85 veterans (75 men, 61% white, mean age 56.9) with symptoms of PTSD participated between October 2015 and March...

DOI: 10.1136/bmjopen-2021-056609 (opens in new tab) Full text (opens in new tab) Anxiety disorders Complementary medicine Clinical trials Mental health

Skepticism about Recent Evidence That Psilocybin “Liberates” Depressed Minds

ACS Chemical Neuroscience August 24, 2022 Manoj K. Doss, Frederick S. Barrett, Philip R. Corlett 21 citations

A recent paper in Nature Medicine found that psilocybin therapy in patients with depression decreased brain network modularity (measured with task-free functional magnetic resonance imaging), an effect supposedly not found with the selective serotonin reuptake inhibitor S-citalopram. This decrease in network modularity also correlated with depression. Here, we raise several issues with this...

DOI: 10.1021/acschemneuro.2c00461 (opens in new tab) Psilocybin Ambiguity Sertindole Modularity biology +4

Mental and physical training with meditation and aerobic exercise improved mental health and well-being in teachers during the COVID-19 pandemic

Frontiers in Human Neuroscience August 23, 2022 Docia Demmin, Steven M. Silverstein, Tracey J. Shors 22 citations

Teachers face significant stressors in relation to their work, placing them at increased risk for burnout and attrition. The COVID-19 pandemic has brought about additional challenges, resulting in an even greater burden. Thus, strategies for reducing stress that can be delivered virtually are likely to benefit this population. Mental and Physical (MAP) Training combines meditation with aerobic...

Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative

Anthropology of Consciousness August 22, 2022 Neşe Devenot, Trey Conner, Richard Doyle 45 citations

Psychedelic or ecodelic medicines (e.g., psilocybin, ayahuasca, iboga) for the care and treatment of addiction, post‐traumatic stress disorder, cancer, cluster headaches, anxiety, and depression have surged to the forefront of discussions about mental health in the US, leading to the emergence of well‐capitalized biotech companies offering multimillion‐dollar IPOs. Venture capital website...

DOI: 10.1111/anoc.12154 (opens in new tab) Counterculture Indigenous Decriminalization Media studies +2

Mindfulness and Relaxation-Based Interventions to Reduce Parental Stress, Anxiety and/or Depressive Symptoms in the Neonatal Intensive Care Unit: A Systematic Review

Journal of clinical psychology in medical settings August 19, 2022 K. H. Ginsberg, Jane M Alsweiler, Mohsen Alyami et al.

Parents with infants in the neonatal intensive care unit (NICU) experience high levels of stress, anxiety, and depression. Mindfulness and relaxation-based interventions are effective in reducing distress in the general postpartum population. The aim of this systematic review was to evaluate whether mindfulness and/or relaxation-based interventions reduce stress, anxiety, and depression in NICU...